WHO ICTRP trial
An open-label, phase II cohort study of vorolanib combined with other therapies…
ChiCTR2400084978 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400084978 |
|---|---|
| Public title | An open-label, phase II cohort study of vorolanib combined with other therapies in patients with soft tissue sarcoma who have failed first-line or higher-level standard therapy |
| Scientific title | An open-label, phase II cohort study of vorolanib combined with other therapies in patients with soft tissue sarcoma who have failed first-line or higher-level standard therapy |
| Primary sponsor | Cancer Hospital Chinese Academy of Medical Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | soft tissue sarcoma |
| Interventions | Cohort 1:vorolanib combined with chemotherapy;Cohort 2:vorolanib combined with epigenetic drugs |
| Registration date | May 29, 2024 |
| Target size | Cohort 1:34;Cohort 2:34 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: